We provide two modes of service:
We provide service to pharmaceutical companies, laboratories or academic institutions to test chemicals on our existing models with the choice of readouts in our portfolio. We are flexible to develop new readouts for your needs as well.
In this model, end users will not need to optimize and assays on their own. We will use use our premises and infrastructure to provide the best service. Our leading scientific experts will also help designing your assays and choice of readouts for your scientific question.
Gel production, automated screening and assessment of versatile end readouts (e.g.: imaging, morphological analyses, quantification with high-end deep learning-based algorithms, biochemical measurements, changes in gene expression, multiplex analyses, immunohistochemical detection and many more) will be performed in-house. Detailed results will be provided to the users as hard-copy and in electronic formats.
This service is ideal for testing a small number of chemicals (e.g.: 100-50,000).
Please contact us for specific discussion on every individual case.
For screening campaigns that require a larger scale of optimization and materials use, we offer a unique assay co-development to the end user. This includes customized optimization of the assays in various automation systems, development of new readouts according to the needs of the user, and advanced data storage and documentation capacity. Licensing terms and conditions can be discussed for long-term adaptation of the technology to the user's premises.
This model is ideal for screening campaigns that test more than 50,000 compounds/chemicals. Please contact us for specific discussion on every individual case.
To get more information on our services please visit individual product pages and feel free to contact us! We would be happy to give you more information and develop a strategy together!
Copyright © 2023 All Rights Reserved - Neuron D GmbH
Powered by Website Builder
We are excited to announce that Neuron D selected as one of the top 12 startups of 2023 by Nature Awards The Spinoff Prize in partnership with Merck! A feature article on Neuron D published in Nature.